Treadwell Therapeutics

Risk score

57
Large logo of Treadwell Therapeutics

Headquarters

Flag of United States of AmericaUnited States of America

Treadwell Therapeutics is an oncology company in the clinical development phase that is capitalizing on the weaknesses of cancer cells to create unique and top-notch small molecules to meet the needs of cancer patients. Leveraging distinctive innovations from our founders, collaborators, and the highly skilled scientists at TIO Discovery, we are progressing a series of innovative clinical candidates with the potential to target genomic instability across various cancers and previously unexplored immuno-oncology objectives.